SC 13G

Company

Aurinia Pharmaceuticals Inc.

Filed

February 17, 2015

Accession Number

0001062993-15-000908

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →